Summary & Overview
HCPCS G2134: Frailty with Dispensed Dementia Medication
HCPCS Level II code G2134 denotes patients aged 66 and older with at least one claim or encounter for frailty and a dispensed dementia medication during the measurement period or in the year prior. Nationally, this code is used to identify older adults with concurrent frailty and active dementia pharmacotherapy, informing quality measurement, care coordination, and medication safety monitoring for a high-risk population. Key payers evaluated include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn the clinical context of G2134, typical sites of service, how the code is applied for quality reporting and encounter documentation, and which payers commonly recognize the measure. The publication summarizes benchmarks where available, notes policy updates relevant to measurement and reporting, and outlines implications for clinical workflows and data capture. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code G2134 identifies patients 66 years of age or older who have at least one claim or encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period. This measure captures patient-level documentation tying a frailty encounter to dementia medication dispensing.
-
Service type: Medication management / condition monitoring tied to frailty and dementia
-
Typical site of service: Ambulatory care settings, outpatient clinics, primary care, geriatrics, and community-based care where medication dispensing and diagnosis coding occur
Clinical & Coding Specifications
Clinical Context
A typical patient is an ambulatory older adult aged 66 or older who presents for primary care follow-up or geriatric assessment after prior diagnoses of frailty and cognitive decline. The patient has at least one documented encounter coded for frailty and either a current or recently dispensed medication indicated for dementia (for example donepezil, memantine, rivastigmine, or galantamine) during the measurement period or the year prior. The clinical workflow typically includes medication reconciliation, confirmation of dementia medication fill history through pharmacy records or patient/ caregiver report, assessment of functional status and frailty measures (e.g., gait speed, unintentional weight loss, exhaustion, low physical activity), and documentation of frailty in the problem list or encounter note. Encounters may occur in an outpatient clinic, geriatric specialty clinic, long-term care facility, or home health visit. Documentation required for billing includes patient age (≥66 years), encounter diagnosis supporting frailty, and evidence of a dispensed dementia medication within the specified timeframe. Coordination with pharmacy benefits managers and reconciliation of Part D prescription fills is often part of the workflow for Medicare patients.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the service required substantially greater work than typical and additional documentation justifies higher payment. |